Taiwan FDA registration 5965a9ab0d5f0568a958f61b98c9abfd
Qingli Maxim Bio Resorbable Bone Replacement Material
TW: 擎力美賽諾斯生物可吸收骨替代材料
Taiwan·Risk Class 2·ZHENPENG BIOTECH CO., LTD.·Registered Oct 06, 2020 – Oct 06, 2025ExpiredRegistration details
- Analysis ID
- 5965a9ab0d5f0568a958f61b98c9abfd
Company information
- Manufacturer
- ZHENPENG BIOTECH CO., LTD.
- Manufacturer Country
- Taiwan, Province of China
- Authorized Representative
- XELITE BIOMED LTD.
Product details
- Intended Use
- For details, it is Chinese approved copy of the imitation order
- Product Type (Level 1)
- N Orthopedics
- Product Type (Level 2)
- N.3045 Absorbable Calcium Salt Bone Cavity Filling Device
- Import Information
- Contract manufacturing;; Domestic
Dates and status
- Registration Date
- Oct 06, 2020
- Expiry Date
- Oct 06, 2025
About this record
Access comprehensive regulatory information for Qingli Maxim Bio Resorbable Bone Replacement Material in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 2 medical device is registered under number 5965a9ab0d5f0568a958f61b98c9abfd and manufactured by ZHENPENG BIOTECH CO., LTD.. The authorized representative in Taiwan is XELITE BIOMED LTD..
This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.
Free DatabasePowered by Pure Global AI89,000+ Devices